Biogen MA, Inc. v. Japanese Foundation for Cancer Research
Certiorari Denied
Petition for certiorari denied on March 21, 2016.
Issue
Whether the Leahy-Smith America Invents Act eliminated federal district courts" jurisdiction over patent interference actions under 35 U.S.C. § 146.
Nov 9, 2015Petition for a writ of certiorari filed. (Response due December 10, 2015)
Dec 4, 2015Order extending time to file response to petition to and including January 11, 2016, for all respondents.
Dec 10, 2015Brief amicus curiae of Merck & Co., Inc. filed.
Dec 10, 2015Brief amicus curiae of Sarepta Therapeutics, Inc. filed.
Dec 28, 2015Order further extending time to file response to petition to and including February 10, 2016.
Feb 10, 2016Brief of respondents Japanese Foundation for Cancer Research, et al. in opposition filed.
Feb 23, 2016Reply of petitioner Biogen MA, Inc. filed.
Feb 24, 2016DISTRIBUTED for Conference of March 18, 2016.
Mar 21, 2016Petition DENIED.
Recommended Citation: Biogen MA, Inc. v. Japanese Foundation for Cancer Research, SCOTUSblog, https://www.scotusblog.com/cases/biogen-ma-inc-v-japanese-foundation-for-cancer-research/